Learn about Topamax (topiramate), from its FDA-approved uses for migraine and seizures to side effects like weight loss to dosage info and safety tips. Topiramate, marketed as Topamax among other names, is an oral medication primarily prescribed for the treatment of epilepsy and the prophylaxis of migraines. [8] Overview: Topiramate is used to treat or prevent seizures. It is also used to prevent migraines. It may work by affecting certain signals in the brain. Common side effects include dizziness. Topamax (generic name: topiramate) is not a controlled substance in the United States, but it is still a prescription‑only medicine with important safety concerns and specific approved uses. It is not known to be addictive or habit‑forming, and it is not an opioid, benzodiazepine, or stimulant drug. Continue reading Topamax (topiramate) is used to prevent seizures in adults and children and to prevent migraine headaches. Learn about side effects, interactions and indications. Eligible patients using commercial or private insurance can save on out-of-pocket costs for TOPAMAX ® (topiramate). Eligible patients pay $4 per fill. There is a $150 limit for each 30-day supply. There is a maximum program benefit of $1,800 or 12 fills per calendar year, whichever comes first. Learn about side effects, uses, dosage, and more for Topamax (topiramate). It’s a prescription drug for migraine and epilepsy in children and adults. Concomitant administration of phenytoin or carbamazepine with TOPAMAX® resulted in a clinically significant decrease in plasma concentrations of topiramate when compared to TOPAMAX® given alone. Topamax (topiramate) is FDA-approved to treat seizures in adults and children and reduce the frequency of migraine headaches in people 12 years of age and older. While Topamax is effective, it has potentially serious side effects like eye issues, kidney stones and metabolic acidosis (acid buildup). Fact Checked Why Trust Drugwatch? TOPAMAX is indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older.